Huntington National Bank’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-17
| Closed | -$579 | – | 4176 |
|
|
2025
Q1 | $579 | Hold |
17
| – | – | ﹤0.01% | 2441 |
|
|
2024
Q4 | $669 | Sell |
17
-287
| -94% | -$11.3K | ﹤0.01% | 2454 |
|
|
2024
Q3 | $14.3K | Hold |
304
| – | – | ﹤0.01% | 1625 |
|
|
2024
Q2 | $16.4K | Hold |
304
| – | – | ﹤0.01% | 1523 |
|
|
2024
Q1 | $20.7K | Hold |
304
| – | – | ﹤0.01% | 1447 |
|
|
2023
Q4 | $19K | Buy |
304
+34
| +13% | +$2.13K | ﹤0.01% | 1429 |
|
|
2023
Q3 | $12.3K | Hold |
270
| – | – | ﹤0.01% | 1498 |
|
|
2023
Q2 | $15.2K | Hold |
270
| – | – | ﹤0.01% | 1446 |
|
|
2023
Q1 | $12.2K | Sell |
270
-15
| -5% | -$678 | ﹤0.01% | 1471 |
|
|
2022
Q4 | $11.6K | Sell |
285
-5
| -2% | -$203 | ﹤0.01% | 1447 |
|
|
2022
Q3 | $19K | Hold |
290
| – | – | ﹤0.01% | 1305 |
|
|
2022
Q2 | $17K | Hold |
290
| – | – | ﹤0.01% | 1387 |
|
|
2022
Q1 | $18K | Hold |
290
| – | – | ﹤0.01% | 1402 |
|
|
2021
Q4 | $22K | Hold |
290
| – | – | ﹤0.01% | 1342 |
|
|
2021
Q3 | $32K | Sell |
290
-160
| -36% | -$17.7K | ﹤0.01% | 1095 |
|
|
2021
Q2 | $73K | Buy |
450
+160
| +55% | +$26K | ﹤0.01% | 826 |
|
|
2021
Q1 | $35K | Hold |
290
| – | – | ﹤0.01% | 941 |
|
|
2020
Q4 | $44K | Buy |
290
+90
| +45% | +$13.7K | ﹤0.01% | 857 |
|
|
2020
Q3 | $17K | Hold |
200
| – | – | ﹤0.01% | 1099 |
|
|
2020
Q2 | $15K | Buy |
+200
| New | +$15K | ﹤0.01% | 1116 |
|